CPT® Code 64612 is used to report chemodenervation of muscle(s) innervated by the facial nerve, most commonly performed using botulinum toxin or similar agents. This procedure temporarily reduces muscle activity by blocking neuromuscular transmission and is used in both therapeutic and functional treatment settings.
Chemodenervation is often utilized to manage neuromuscular conditions, facial spasms, and movement disorders, improving patient comfort and function.
Key Facts About CPT® 64612
- Service type: Therapeutic procedure (chemodenervation)
- Anatomy: Muscle(s) innervated by the facial nerve (cranial nerve VII)
- Medication used: Typically botulinum toxin (reported separately)
- Setting: Office, outpatient clinic, or ambulatory setting
- Provider type: Physicians and qualified healthcare professionals
Common clinical indications:
- Blepharospasm
- Hemifacial spasm
- Facial dystonia
- Synkinesis following facial nerve injury
- Other neuromuscular disorders affecting facial muscles
When to Use CPT® 64612
CPT 64612 is appropriate when:
- Chemodenervation is performed on facial nerve–innervated muscles
- Treatment is medically necessary for neuromuscular or functional conditions
- Injections are administered to reduce involuntary muscle activity or spasm
- The procedure is performed with appropriate technique and anatomical targeting
Examples:
- Treating blepharospasm with botulinum toxin injections
- Managing hemifacial spasm affecting one side of the face
- Addressing facial muscle overactivity due to nerve injury
- Treating functional facial dystonia impacting daily activities
Documentation Requirements
To support CPT 64612 billing, documentation should include:
- Patient identifiers and date of service
- Diagnosis supporting medical necessity
- Specific muscles or regions treated
- Medication used, dosage, and injection sites
- Technique and guidance (if applicable)
- Patient response and tolerance
- Post-procedure plan and follow-up
- Provider signature and credentials
Clear documentation is essential to demonstrate the medical necessity and accuracy of injection-based procedures.
Reimbursement and Coding Considerations
- CPT 64612 is generally covered when medical necessity is established
- Botulinum toxin supply (e.g., J-codes) should be billed separately
- Diagnosis coding should reflect neuromuscular or functional indications
- Units and dosage must be accurately documented
- May require prior authorization depending on payer
- Frequency of treatment may be limited by payer guidelines
Always verify payer-specific policies for chemodenervation procedures and injectable medications.
How OptiMantra Supports Chemodenervation Services
OptiMantra’s integrated EMR and practice management platform streamlines documentation and billing for CPT 64612:
With OptiMantra, providers can:
- Document injection procedures with customizable charting templates
- Track medication usage, dosage, and injection sites
- Link treatments to diagnoses and care plans
- Maintain organized clinical and billing documentation to support compliance
- Monitor treatment response over time
- Simplify coding workflows to support accurate reimbursement
By centralizing procedural and medication documentation, OptiMantra helps practices improve efficiency, ensure compliance, and optimize reimbursement.
Try OptiMantra for free here!
Disclaimer: CPT® codes are maintained by the American Medical Association. This guide is for informational purposes only and does not replace official coding guidelines or payer policies.
.png)
